i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biochemistry
Reference75 articles.
1. Production of recombinant antibodies using bacteriophages;Shukra;Eur. J. Microbiol. Immunol.,2014
2. Engineered proteins with desired specificity: DARPins, other alternative scaffolds and bispecific IgGs;Jost;Curr. Opin. Struct. Biol.,2014
3. The emerging role of new protein scaffold-based agents for treatment of cancer;Weidle;Cancer Genomics Proteomics,2013
4. Novel protein scaffolds as emerging therapeutic proteins: from discovery to clinical proof-of-concept;Wurch;Trends Biotechnol.,2012
5. Structure of a nanobody-stabilized active state of the β(2) adrenoceptor;Rasmussen;Nature,2011
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites;Nature Communications;2024-08-22
2. Phage display technology and its impact in the discovery of novel protein-based drugs;Expert Opinion on Drug Discovery;2024-06-18
3. PROSCA: an online platform for humanized scaffold mining facilitating rational protein engineering;Nucleic Acids Research;2024-05-13
4. Development of N-Terminally Modified Variants of the CXCR4-Antagonistic Peptide EPI-X4 for Enhanced Plasma Stability;Journal of Medicinal Chemistry;2023-11-08
5. Discovery and design of G protein-coupled receptor targeting antibodies;Expert Opinion on Drug Discovery;2023-03-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3